… The coronavirus disease 2019 (COVID-19) pandemic caused by a novel severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in over 537 million confirmed …

… Plasma concentrations of extracellular vesicles (EVs) originating from cells involved in
COVID-19-… Blood samples of consecutive COVID-19 patients admitted to a medical Unit were …

… need for an effective therapy for COVID-19 patients, a phase I … as a therapy for ARDS
secondary to COVID-19 [[23]]. While … to use EVs as a treatment to battle the COVID-19 pandemic. …

… approach to the management of COVID-19. Recently, extracellular vesicle (EV)-based …
EVs are extracellular vesicles containing specific biomolecules which play an important role …

… The role of EVs in COVID-19 related hemostasis may depend on cells of origin, vesicular …
We hypothesized that the procoagulant potential of EV isolates from COVID-19 (+) patient …

… could help to delineate specific signaling pathways in COVID-19 different from other forms
… circulating extracellular vesicles from patients with COVID-19 pneumonia, COVID-19 ARDS, …

… of biological characteristics of recovered COVID-19 patients as clinical characteristics do. In
… extracellular vesicles (EVs) of plasma from 19 healthy subjects and 67 recovered COVID-19 …

… coronavirus disease 2019 (COVID-19) have a high rate of thrombosis. We hypothesized that
severe acute respiratory syndrome coronavirus 2 … TF-positive extracellular vesicles (EV) that …

… , and acute respiratory distress syndrome, with extracellular vesicles (EVs) being involved in
… reflect COVID-19 disease severity. Thirty-six patients with symptomatic COVID-19 infection …

… COVID-19 patients recover gradually upon appropriate interventions. Viruses were reported
to utilize the small extracellular vesicles (… of plasma of recovered COVID-19 patients (RCs). …